John L. Tonkinson

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA.

Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI.

BioHelix Corp. operates as a molecular diagnostic company, that develops nucleic acid technologies for molecular diagnostics. The firm focuses on the development of simple molecular diagnostic tests for the near patient setting. It offers in vitro diagnostic products, such as IsoAmp, an herpes simplex viruses (HSV) assay test for the direct, qualitative detection of HSV DNA in male and female genital and oral lesions. The company was founded by Huimin Kong in 2004 and is headquartered in Beverly, MA.

BioCision LLC operates as a life science research and development company. Its products include cell cryopreservation systems, sample cooling, freezing, snap-freezing, ice-free cooling systems, tube temperature and plate temperature management, support platforms, sample transport, cryostorage boxes, cryogenic vials, ice pans and buckets and other accessories. The firm’s products protect temperature-sensitive therapeutics, biological samples and biomaterials. The company was founded by Brian Schryver and Rolf O. Ehrhardt in 2007 and is headquartered in San Rafael, CA.

Magellan Diagnostics, Inc. develops diagnostic laboratory products. It products include LeadCare II System and LeadCare Ultra. The firm's services encompass blood lead and zinc protoporphyrin analysis. The company was founded in 1968 and is headquartered in North Billerica, MA.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY.

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators.

Adarza BioSystems, Inc. develops and manufacturers a multiplex immunoassay technology that can identify proteins and genetic markers in medical specimens. The firm operates as a medical diagnostics company which also develops a rapid and label-free biological assay platform for measuring clinical and point-of-care samples and also its technology allows hundreds of tests to be run simultaneously on a single chip. The company was founded by Benjamin L. Miller, Randolph R. Henke, Terry Gronwall and Christopher C. Striemer in 2008 and is headquartered in St. Louis, MO.

Roche Diagnostics develops test and diagnostic solutions in vitro to serve the patients. The company was founded on February 4, 1991 and is headquartered in Meylan, France.

Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors.

Stratos Genomics, Inc. develops nucleic acid sequencing methods. The firm's Sequencing by Expansion (SBX) solution offers a single-molecule detection process that allows whole genome sequencing. The company was founded by Allan H. Stephan, Mark Kokoris, and Robert McRuer in 2007 and is headquartered in Seattle, WA.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

GestVision, Inc. provides care diagnostic test for preeclampsia. The firm delivers insights for safer pregnancies beginning with a diagnostic for preeclampsia, a poorly understood pregnancy- related condition. It is developing a point of care diagnostic product that provides essential information to OBGYNs for improving patient management and outcomes. The company was founded in 2014 by Wendy L. Davis and is headquartered in Groton, CT.

Spinomix SA develops a software technology platform. The private company is based in Lausanne, Switzerland and has subsidiaries in Switzerland.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom.

DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France.

MedCision LLC provides medical related software solutions. Its products include ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems and Custom ULT Freezer Storage Boxes. The firm develops and commercializes technologies that automate and standardize preclinical and clinical biologics handling for critical post-manufacturing processes. The company was founded by Rolf O. Ehrhardt in 2016 and is headquartered in San Rafael, CA.

Lyssn.io, Inc. offers an AI platform to improve the quality of clinical and non-clinical interactions, leading to better engagement and outcomes. Based in an undisclosed location, Lyssn builds products that can examine and support the effectiveness of therapy. The American company's AI-enabled technology solutions facilitate counselor training and supervision and offer ongoing skill development opportunities for psychotherapy professionals. The private company believes access to consistent, unbiased performance feedback can assist in a therapist's own reflection and growth, improve training in specific evidence-based practices and skills, and deepen the process of supervision. The company was founded in 2017 by Dave Atkins, Mike Tanana, Zac Imel, Tad Hirsch, Shri Narayanan, with Dave Atkins as the CEO since then.